Community-acquired Listeria monocytogenes meningitis in adults

Matthijs C Brouwer1, Diederik van de Beek, Sebastiaan G B Heckenberg

  • 1Department of Neurology, Center of Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. m.c.brouwer@amc.uva.nl

Abstract

Insights

Listeria monocytogenes meningitis, a common cause of bacterial meningitis, often presents without classic symptoms or typical cerebrospinal fluid findings. Many patients receive inadequate initial antimicrobial therapy, impacting outcomes.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Microbiology

Background:

  • Listeria monocytogenes is a significant cause of bacterial meningitis, particularly in immunocompromised individuals and the elderly.
  • Understanding the clinical presentation and management of Listeria monocytogenes meningitis is crucial for improving patient outcomes.

Purpose of the Study:

  • To prospectively evaluate clinical features, diagnostic findings, and treatment outcomes of community-acquired Listeria monocytogenes meningitis.
  • To assess the adequacy of initial antimicrobial therapy and its relation to patient outcomes.

Main Methods:

  • A nationwide prospective study in The Netherlands involving 30 episodes of Listeria monocytogenes meningitis.
  • Patients' clinical data, cerebrospinal fluid analysis, and initial antimicrobial regimens were analyzed.
  • Patient outcomes were assessed using the Glasgow outcome score.

Main Results:

  • Listeria monocytogenes meningitis occurred in immunocompromised or elderly patients (>50 years old).
  • Classic meningitis symptoms were infrequent (43%), and typical cerebrospinal fluid findings were absent in 23% of cases.
  • 17% mortality and 27% unfavorable outcomes were observed; inadequate initial antimicrobial therapy did not correlate with outcomes.

Conclusions:

  • Listeria monocytogenes meningitis may not present with typical clinical or cerebrospinal fluid findings, challenging early diagnosis.
  • A substantial proportion of patients received initial antimicrobial therapy lacking coverage for Listeria monocytogenes.
  • Despite inadequate initial therapy not being linked to outcomes in this study, appropriate antimicrobial selection remains critical.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...